Oxidative stress measured by thioredoxin reductase level as potential biomarker for prostate cancer.
about
Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer.Birth of MTH1 as a therapeutic target for glioblastoma: MTH1 is indispensable for gliomatumorigenesisDiagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis.Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model.Total Oxidant/Antioxidant Status in Sera of Patients with Esophageal Cancer.Selenoproteins and Metastasis.
P2860
Oxidative stress measured by thioredoxin reductase level as potential biomarker for prostate cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Oxidative stress measured by t ...... biomarker for prostate cancer.
@ast
Oxidative stress measured by t ...... biomarker for prostate cancer.
@en
type
label
Oxidative stress measured by t ...... biomarker for prostate cancer.
@ast
Oxidative stress measured by t ...... biomarker for prostate cancer.
@en
prefLabel
Oxidative stress measured by t ...... biomarker for prostate cancer.
@ast
Oxidative stress measured by t ...... biomarker for prostate cancer.
@en
P2093
P2860
P1476
Oxidative stress measured by t ...... biomarker for prostate cancer.
@en
P2093
Weibing Zhang
Xinghuan Wang
Xinming Zheng
P2860
P304
P577
2015-08-15T00:00:00Z